BIOLARGO, INC. (BLGO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 7M 14M 21M Q3 '16: 270K Q4 '16: 281.1K Q1 '17: 313.2K Q2 '17: 374.2K Q3 '17: 383.9K Q4 '17: 516K Q1 '18: 834K Q2 '18: 1.1M Q3 '18: 1.2M Q4 '18: 1.5M Q1 '19: 1.5M Q2 '19: 1.6M Q3 '19: 1.8M Q4 '19: 1.9M Q1 '20: 1.9M Q2 '20: 1.9M Q3 '20: 2.1M Q4 '20: 2.4M Q1 '21: 2.6M Q2 '21: 2.6M Q3 '21: 2.7M Q4 '21: 2.5M Q1 '22: 2.9M Q2 '22: 3.8M Q3 '22: 4.6M Q4 '22: 5.9M Q1 '23: 8.7M Q2 '23: 8.8M Q3 '23: 10M Q4 '23: 12.2M Q1 '24: 13.2M Q2 '24: 16.8M Q3 '24: 18.5M Q4 '24: 17.8M Q1 '25: 16.3M Q2 '25: 14.1M Q3 '25: 10.8M Q4 '25: 7.8M Q1 '26: 5.6M Q2 '26: 4.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 3M 6M 9M Q3 '16: 173K Q4 '16: 175.2K Q1 '17: 190.9K Q2 '17: 194.2K Q3 '17: 127.8K Q4 '17: 193K Q1 '18: 269.5K Q2 '18: 368.9K Q3 '18: 475.2K Q4 '18: 621K Q1 '19: 693K Q2 '19: 765K Q3 '19: 878K Q4 '19: 916K Q1 '20: 923K Q2 '20: 942K Q3 '20: 1M Q4 '20: 1.2M Q1 '21: 1.3M Q2 '21: 1.3M Q3 '21: 1.2M Q4 '21: 1.1M Q1 '22: 1.4M Q2 '22: 1.8M Q3 '22: 2.2M Q4 '22: 2.9M Q1 '23: 4.2M Q2 '23: 4.3M Q3 '23: 5M Q4 '23: 6.2M Q1 '24: 6.6M Q2 '24: 7.9M Q3 '24: 8.2M Q4 '24: 7.9M Q1 '25: 7.1M Q2 '25: 6.4M Q3 '25: 5M Q4 '25: 3.4M Q1 '26: 2.4M Q2 '26: 1.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

-21M -14M -7M 0 7M 14M 21M Q3 '16: -4.6M Q4 '16: -4.9M Q1 '17: -5.1M Q2 '17: -5.3M Q3 '17: -5.6M Q4 '17: -5.9M Q1 '18: -6.1M Q2 '18: -6.2M Q3 '18: -6.4M Q4 '18: -6.4M Q1 '19: -6.5M Q2 '19: -6.3M Q3 '19: -6.5M Q4 '19: -6.7M Q1 '20: -6.7M Q2 '20: -7.3M Q3 '20: -7.3M Q4 '20: -7.6M Q1 '21: -7.7M Q2 '21: -7.4M Q3 '21: -7M Q4 '21: -6.8M Q1 '22: -6.6M Q2 '22: -6.3M Q3 '22: -5.7M Q4 '22: -5.4M Q1 '23: -4.2M Q2 '23: -4.4M Q3 '23: -5M Q4 '23: -4.6M Q1 '24: -4.9M Q2 '24: -4.2M Q3 '24: -3.7M Q4 '24: -4.3M Q1 '25: -5.4M Q2 '25: -6.3M Q3 '25: -12.5M Q4 '25: -14.9M Q1 '26: -16.2M Q2 '26: -18.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-21M -14M -7M 0 7M 14M 21M Q3 '16: -7.1M Q4 '16: -8.1M Q1 '17: -8.8M Q2 '17: -9.7M Q3 '17: -9.4M Q4 '17: -9.5M Q1 '18: -9.7M Q2 '18: -10.7M Q3 '18: -10.8M Q4 '18: -10.7M Q1 '19: -11M Q2 '19: -9.4M Q3 '19: -10.9M Q4 '19: -11.4M Q1 '20: -11.3M Q2 '20: -12M Q3 '20: -10.5M Q4 '20: -9.7M Q1 '21: -9M Q2 '21: -8.1M Q3 '21: -7.1M Q4 '21: -6.9M Q1 '22: -6.6M Q2 '22: -6.1M Q3 '22: -5.5M Q4 '22: -5.1M Q1 '23: -4.1M Q2 '23: -4.4M Q3 '23: -5M Q4 '23: -4.6M Q1 '24: -4.9M Q2 '24: -4.1M Q3 '24: -3.6M Q4 '24: -4.3M Q1 '25: -5.5M Q2 '25: -6.6M Q3 '25: -12.8M Q4 '25: -15.2M Q1 '26: -16.7M Q2 '26: -18.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 4M 8M 12M Q4 '15: 62.1K Q1 '16: 61.8K Q2 '16: 69.8K Q3 '16: 97K Q4 '16: 105.9K Q1 '17: 122.3K Q2 '17: 180K Q3 '17: 256.1K Q4 '17: 323K Q1 '18: 463.5K Q2 '18: 591K Q3 '18: 589.3K Q4 '18: 742.8K Q1 '19: 771.8K Q4 '20: 1.2M Q1 '21: 1.3M Q2 '21: 1.3M Q3 '21: 1.4M Q4 '21: 1.4M Q1 '22: 1.5M Q2 '22: 2M Q3 '22: 2.4M Q4 '22: 3M Q1 '23: 4.5M Q2 '23: 4.4M Q3 '23: 4.9M Q4 '23: 6.1M Q1 '24: 6.7M Q2 '24: 8.9M Q3 '24: 10.3M Q4 '24: 9.9M Q1 '25: 9.2M Q2 '25: 7.7M Q3 '25: 5.8M Q4 '25: 4.4M Q1 '26: 3.2M Q2 '26: 2.5M Q1 '16 Q2 '17 Q3 '18 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q3 '16: -3.3M Q4 '16: -3.7M Q1 '17: -3.9M Q2 '17: -4.1M Q3 '17: -4M Q4 '17: -4.3M Q1 '18: -4.1M Q2 '18: -4.3M Q3 '18: -4.3M Q4 '18: -3.9M Q1 '19: -3.8M Q2 '19: -3.7M Q3 '19: -4M Q4 '19: -4.4M Q1 '20: -4.3M Q2 '20: -4.6M Q3 '20: -4.6M Q4 '20: -4.2M Q1 '21: -4.2M Q2 '21: -4.2M Q3 '21: -3.8M Q4 '21: -3.9M Q1 '22: -4.2M Q2 '22: -3.7M Q3 '22: -3.8M Q4 '22: -2.8M Q1 '23: -1.7M Q2 '23: -2.4M Q3 '23: -2.3M Q4 '23: -2.4M Q1 '24: -1.8M Q2 '24: -508K Q3 '24: -1.3M Q4 '24: -3.2M Q1 '25: -5.5M Q2 '25: -7.5M Q3 '25: -8.6M Q4 '25: -8.3M Q1 '26: -9.4M Q2 '26: -10.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '13: 72.6M Q3 '13: 73.2M Q1 '14: 76.4M Q2 '14: 81.2M Q3 '14: 81.2M Q1 '15: 83M Q2 '15: 83.4M Q3 '15: 84.5M Q1 '16: 85.8M Q2 '16: 86.4M Q3 '16: 88.1M Q1 '17: 94.4M Q2 '17: 97.8M Q3 '17: 100.8M Q1 '18: 104.7M Q2 '18: 118.7M Q3 '18: 130.4M Q1 '19: 142.2M Q2 '19: 145.7M Q3 '19: 156.4M Q1 '20: 168.9M Q2 '20: 181.6M Q3 '20: 210.2M Q1 '21: 233.7M Q2 '21: 243.7M Q3 '21: 252.9M Q1 '22: 260.8M Q2 '22: 265.9M Q3 '22: 270.7M Q1 '23: 280.7M Q2 '23: 284.9M Q3 '23: 287.9M Q1 '24: 294.3M Q2 '24: 296.4M Q3 '24: 300.5M Q1 '25: 301.3M Q2 '25: 303.2M Q3 '25: 309M Q1 '26: 318.7M Q2 '26: 321M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.12 -0.08 -0.04 0.00 0.04 0.08 0.12 Q3 '16: -0.08 Q4 '16: -0.10 Q1 '17: -0.10 Q2 '17: -0.11 Q3 '17: -0.10 Q4 '17: -0.10 Q1 '18: -0.10 Q2 '18: -0.10 Q3 '18: -0.10 Q4 '18: -0.09 Q1 '19: -0.09 Q2 '19: -0.07 Q3 '19: -0.07 Q4 '19: -0.07 Q1 '20: -0.06 Q2 '20: -0.06 Q3 '20: -0.05 Q4 '20: -0.04 Q1 '21: -0.04 Q2 '21: -0.04 Q3 '21: -0.04 Q4 '21: -0.04 Q1 '22: -0.04 Q2 '22: -0.04 Q3 '22: -0.03 Q4 '22: -0.03 Q1 '23: -0.02 Q2 '23: -0.02 Q3 '23: -0.02 Q4 '23: -0.01 Q1 '24: -0.01 Q2 '24: -0.01 Q3 '24: -0.00 Q4 '24: -0.01 Q1 '25: -0.01 Q2 '25: -0.01 Q3 '25: -0.03 Q4 '25: -0.03 Q1 '26: -0.04 Q2 '26: -0.05 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.